StudyFinder

Expansion Cohort Study of Disulfiram and Chemotherapy in Pancreas Cancer Patients

Recruiting

Disulfiram is a potential inhibitor of muscle degradation and may reduce tumor induced muscle wasting. Emerging research also suggests it might have anti-cancer effects. This study examines whether targeting muscle loss with Disulfiram will reverse disability and eventually improve survival in patients with incurable pancreatic cancer. It tests the safety, tolerability and potential benefit of disulfiram (Antabuse®) in combination with chemotherapy

I'm interested

This study is NOT accepting healthy volunteers

Stage IV Pancreatic Cancer AJCC v8, Metastatic Pancreatic Adenocarcinoma, Refractory Malignant Solid Neoplasm

Patricia Beckmann - beckm001@umn.edu
Aminah Jatoi
Phase II
15-003194
NCT02671890
See this study on ClinicalTrials.gov

Back